HUMN Pharmaceuticals Inc.
Winnipeg, MB R3R 2L6, Canada
HUMN Pharmaceuticals Inc. was created to develop highly effective and clinically proven solutions,
devoid of adverse side effects and dependency free, for ailments and conditions that affect a very large percentage of our global population.
Incorporated in Canada in December 2008.
Four products currently approved for sale in Canada and U.S.
Multiple additional products in development.
Highly experienced management team in place.
Five year Distribution Agreement in place with Alliance Healthcare in the U.K.
One product is on the market now. Four more being introduced in 2015.
As of January 31, 2015 product being sold through more than 1,200 retail locations.
Retail outlets include pharmacies, chiropractors, physiotherapists and specialty healthcare providers. Other niche market channels are dermatologists, insurance companies, sporting goods stores, grocery stores and convenience stores and kiosks among others.
Another major future market potential is veterinarians.
Products / Services
Pain Relief Cream – TPR20
Only lidocaine OTC product on the market.
Combines lidocaine with menthol and 18 other natural ingredients.
Extremely effective, very versatile and devoid of adverse side effects.
Currently being sold in the USA and Canada.
Clinical Trials planned to access specific niche markets such as dermatologists for shingles, insurance companies for soft tissue damage and hospitals and clinics for mammography applications.
Itch, Burn and Sunburn Relief
These products are formulated and have regulatory approval for sale in both Canada and the US.
They are derivatives of our initial lidocaine/menthol combination and are again unique in their application of lidocaine.
They are being introduced to the North American market place starting in May 2015.
Hemorrhoid Relief Cream
Our Hemorrhoid Relief Cream is extremely effective in relieving the symptoms and pain associated with hemorrhoids.
A DIN (Canadian Drug Identification Number) application will be filed in March 2015 and the product will be introduced to the market in July 2015.
Regulatory guidelines in both Canada and the USA provide assurance that our hemorrhoid product will be approved for sale in both countries.
President Executive Officer
Blair J. McInnes
Founder, Chairman, President. 15 years experience in the industry. Successful career in manufacturing and sales. Global network of business associates.
Chief Executive Officer
CEO. Former Chief Operating Officer of the Winnipeg Health Sciences Centre, and former CFO Sunnybrook Health Science Centre. Mr. Topp worked with Hay Group Health Care consulting for 7 years leading numerous high level and complex health care related assignments and has published several papers related to the industry.
Chief Financial Officer
Paul Leslie Hammond, CPA CA
CFO. Chartered Accountant, Economics and Commerce degree (BA) from Simon Fraser University. Senior executive experience in international project management, capital markets and mergers and acquisitions.